Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Guillin

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Pediatrics|May 1, 1986
Effect of L-asparaginase therapy for acute lymphoblastic leukemia on plasma vitamin K-dependent coagulation factors and inhibitorsA Bezeaud, L Drouet, G Leverger, et al.
Blood|December 1, 1992
Thrombin interaction with platelet glycoprotein Ib: effect of glycocalicin on thrombin specificityM Jandrot-Perrus, K J Clemetson, M G Huisse, et al.
Biochemistry|July 16, 1996
Bothrojaracin: a potent two-site-directed thrombin inhibitorV Arocas, R B Zingali, M C Guillin, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1992
Thrombin binding to platelet membrane glycoprotein IbM Jandrot-Perrus, M G Huisse, C Ternisien, et al.
Biochemistry|August 25, 1992
Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activityT Miyata, R Aruga, H Umeyama, et al.
Thrombosis and Haemostasis|September 1, 1996
Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemiaD Helley, A Eldor, R Girot, et al.
Thrombosis Research|August 15, 1982
Heparin-associated thrombocytopenia. In vitro effects of different molecular weight heparin fractionsM G Huisse, M C Guillin, A Bezeaud, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADPF Adam, T J Verbeuren, J-L Fauchère, et al.
Lancet (London, England)|February 25, 1995
Budd-Chiari syndrome and factor V Leiden mutationM H Denninger, K Beldjord, F Durand, et al.
Thrombosis Research|February 1, 1977
The purification of human acarboxy prothrombin. Characterization of its derivatives after thrombin cleavageM C Guillin, D L Aronson, A Bezeaud, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Pediatrics|May 1, 1986
Effect of L-asparaginase therapy for acute lymphoblastic leukemia on plasma vitamin K-dependent coagulation factors and inhibitorsA Bezeaud, L Drouet, G Leverger, et al.
Blood|December 1, 1992
Thrombin interaction with platelet glycoprotein Ib: effect of glycocalicin on thrombin specificityM Jandrot-Perrus, K J Clemetson, M G Huisse, et al.
Biochemistry|July 16, 1996
Bothrojaracin: a potent two-site-directed thrombin inhibitorV Arocas, R B Zingali, M C Guillin, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1992
Thrombin binding to platelet membrane glycoprotein IbM Jandrot-Perrus, M G Huisse, C Ternisien, et al.
Biochemistry|August 25, 1992
Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activityT Miyata, R Aruga, H Umeyama, et al.
Thrombosis and Haemostasis|September 1, 1996
Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemiaD Helley, A Eldor, R Girot, et al.
Thrombosis Research|August 15, 1982
Heparin-associated thrombocytopenia. In vitro effects of different molecular weight heparin fractionsM G Huisse, M C Guillin, A Bezeaud, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADPF Adam, T J Verbeuren, J-L Fauchère, et al.
Lancet (London, England)|February 25, 1995
Budd-Chiari syndrome and factor V Leiden mutationM H Denninger, K Beldjord, F Durand, et al.
Thrombosis Research|February 1, 1977
The purification of human acarboxy prothrombin. Characterization of its derivatives after thrombin cleavageM C Guillin, D L Aronson, A Bezeaud, et al.
Pageof 8